However, it has been reported that while there may not be significant differences in β-catenin levels in the ASM between asthmatic and non-asthmatic individuals, the expression of genes controlled by β-catenin, including WISP1, is increased in a mouse model of OVA-induced asthma [ 77 ].
← all excerpts
WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD.
1
—
—